☐
|
Preliminary Proxy Statement
|
☐
|
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
|
☒
|
Definitive Proxy Statement
|
☐
|
Definitive Additional Materials
|
☐
|
Soliciting Material Pursuant to §240.14a-12
|
Payment of Filing Fee (Check the appropriate box):
|
||
☒
|
No fee required.
|
|
☐
|
Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
|
|
(1)
|
Title of each class of securities to which transaction applies:
|
|
(2)
|
Aggregate number of securities to which transaction applies:
|
|
(3)
|
Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (Set forth the amount on which the filing fee is calculated and state how it was determined):
|
|
(4)
|
Proposed maximum aggregate value of transaction:
|
|
(5)
|
Total fee paid:
|
|
☐
|
Fee paid previously with preliminary materials.
|
|
☐
|
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration
statement number, or the form or schedule and the date of its filing.
|
|
(1)
|
Amount Previously Paid:
|
|
(2)
|
Form, Schedule or Registration Statement No.:
|
|
(3)
|
Filing Party:
|
|
(4)
|
Date Filed:
|
|
Page
|
|
4
|
|
4
|
|
5
|
|
5
|
|
6
|
|
6
|
|
6
|
|
7
|
|
10 | |
11 | |
12
|
|
16 | |
16 | |
17 | |
18 | |
20 | |
20 | |
30
|
|
31 | |
33 | |
35 | |
37 | |
39 | |
41 | |
41 | |
42 | |
42 | |
43 | |
43 | |
43 |
Name
|
Class
|
Age
|
Position
|
Elected Director (Calendar Year)
|
Current Term Expires
(Calendar Year)
|
Expiration of Term for which Nominated
(Calendar Year)
|
||||||
Director Nominees
|
||||||||||||
Marcel Gani (2)
|
II
|
67
|
Director
|
2015
|
2020
|
2023
|
||||||
Tal Payne (2)
|
II
|
48
|
Director
|
2015
|
2020
|
2023
|
||||||
Continuing Directors
|
||||||||||||
Nadav Zafrir
|
III
|
50
|
Chairman of the Board
|
2019
|
2021
|
|||||||
Avery More (1)(3)
|
III
|
65
|
Director
|
2006
|
2021
|
|||||||
Zivi Lando
|
III
|
55
|
Chief Executive Officer
|
2020
|
2021
|
|||||||
Dan Avida (1)(3)
|
I
|
56
|
Director
|
2007
|
2022
|
|||||||
Yoni Cheifetz (3)
|
I
|
59
|
Director
|
2010
|
2022
|
|||||||
Doron Inbar (1)(2)
|
I
|
70
|
Director
|
2010
|
2022
|
(1) |
Member of the Compensation Committee.
|
(2) |
Member of the Audit Committee.
|
(3) |
Member of the Nominating and Corporate Governance Committee.
|
The Board of Directors recommends a vote FOR the election of each of the two director nominees.
|
• |
appointing, compensating, retaining, evaluating, terminating and overseeing our outside auditor;
|
• |
at least annually, reviewing the independence of our outside auditor;
|
• |
reviewing with our independent registered public accounting firm the matters required to be reviewed by applicable auditing requirements;
|
• |
approving in advance all audit and permissible non-audit services to be performed by our independent registered public accounting firm;
|
• |
meeting to review and discuss with management and the outside auditor the annual audited and quarterly financial statements of the Company and the independent auditor’s reports related to the financial statements;
|
• |
receiving reports from management regarding, and reviewing and discussing the adequacy and effectiveness of, the Company’s disclosure controls and procedures;
|
• |
establishing and overseeing procedures for the confidential anonymous submission of concerns regarding questionable accounting, internal controls, auditing and federal securities law matters;
|
• |
establishing and periodically reviewing policies and procedures for the review, approval, and ratification of related person transactions; and
|
• |
overseeing the preparation of the report of the Audit Committee that SEC rules require to be included in our annual proxy statement.
|
• |
overseeing our overall compensation philosophy, policies, and programs;
|
• |
reviewing and approving corporate goals and objectives relevant to the compensation of our Chief Executive Officer, evaluating the Chief Executive Officer’s performance in light of those goals and objectives, approving grants of
equity awards to the Chief Executive Officer and recommending to the independent directors the Chief Executive Officer’s compensation level based on this evaluation;
|
• |
overseeing the evaluation of other executive officers and approving equity awards to these officers, and setting their compensation based upon the recommendation of the Chief Executive Officer;
|
• |
reviewing and approving the design of other benefit plans pertaining to executive officers;
|
• |
reviewing and approving employment agreements and other similar arrangements between us and our executive officers; and
|
• |
overseeing preparation of the report of the Compensation Committee to the extent required by SEC rules to be included in our annual meeting proxy statement.
|
• |
developing and recommending to the Board criteria for identifying and evaluating director candidates and periodically reviewing these criteria;
|
• |
identifying individuals qualified to become members of our Board of Directors, consistent with criteria approved by our Board of Directors;
|
• |
assessing the contributions and independence of incumbent directors in determining whether to recommend them for reelection to the Board;
|
• |
developing and recommending to our Board of Directors a set of corporate governance guidelines and principles;
|
• |
establishing procedures for the consideration of Board candidates recommended by the Company’s stockholders;
|
• |
recommending to the Board candidates to be elected by the Board to fill vacancies and newly created directorships and candidates for election or reelection at each annual stockholders’ meeting;
|
• |
periodically reviewing the Board’s leadership structure, size, composition, and functioning;
|
• |
overseeing succession planning for positions held by executive offices;
|
• |
overseeing the evaluation of the Board and its committees; and
|
• |
annually reviewing the compensation of directors for service on the Board and its committees and recommend changes in compensation to the Board, as appropriate.
|
Leadership
and
Executive
Experience |
Knowledge of
the Company’s
Business
|
Financial
Expertise
|
Broad
International
Exposure
|
Innovation
and
Technology
|
Independence
|
|
Nadav Zafrir
|
♦
|
♦
|
♦
|
♦
|
♦
|
|
Zivi Lando
|
♦
|
♦
|
♦
|
♦
|
||
Dan Avida
|
♦
|
♦
|
♦
|
♦
|
♦
|
|
Yoni Cheifetz
|
♦
|
♦
|
♦
|
♦
|
♦
|
|
Marcel Gani
|
♦
|
♦
|
♦
|
♦
|
♦
|
|
Doron Inbar
|
♦
|
♦
|
♦
|
♦
|
♦
|
|
Avery More
|
♦
|
♦
|
♦
|
♦
|
♦
|
|
Tal Payne
|
♦
|
♦
|
♦
|
♦
|
♦
|
2018
|
2019
|
|||||||
In thousands of Dollars
|
||||||||
Audit fees(1)
|
815
|
1,149
|
||||||
Audit related fees (2)
|
336
|
10
|
||||||
Tax fees(3)
|
171
|
158
|
||||||
Total audit and related fees
|
1,322
|
1,317
|
(1) |
“Audit fees” are fees for audit services for each of the years shown in this table, including fees associated with the annual audit (including audit of our internal control over financial
reporting for the year ended December 31, 2018 and for the year ended December 31, 2019), reviews of our quarterly financial results submitted on Form 10-Q, Korean statutory audit services and consultations on various accounting
issues.
|
(2) |
“Audit related fees” are fees for financial and tax due diligence with respect to our acquisitions in Korea and Italy.
|
(3) |
Represents professional services rendered for tax compliance, tax advice, tax planning, and review of our Israeli tax returns.
|
The Board of Directors recommends a vote FOR the ratification
of the appointment of EY for 2020. |
The Board of Directors recommends a vote FOR the approval of our executive compensation on an advisory basis.
|
• |
each person known to us to beneficially own 5% or more of the outstanding shares of our common stock;
|
• |
each member of our Board of Directors and director nominees;
|
• |
each of our named executive officers; and
|
• |
the members of our Board of Directors and our executive officers as a group.
|
Shares Beneficially Owned
|
||||||||
Name of Beneficial Owner
|
Shares
|
%
|
||||||
5% Stockholders:
|
||||||||
BlackRock, Inc. (1)
|
3,630,994
|
7.3
|
%
|
|||||
Swedbank Robur Fonder AB (2)
|
2,480,228
|
5.0
|
%
|
|||||
Directors and Named Executive Officers:
|
||||||||
Zivi Lando (3)
|
36,922
|
*
|
||||||
Ronen Faier (4)
|
139,416
|
*
|
||||||
Yoav Galin (5)
|
215,389
|
*
|
||||||
Rachel Prishkolnik (6)
|
18,806
|
*
|
||||||
Uri Bechor
|
-
|
*
|
||||||
Nadav Zafrir (7)
|
1,359
|
*
|
||||||
Dan Avida (8)
|
96,342
|
*
|
||||||
Yoni Cheifetz (9)
|
46,831
|
*
|
||||||
Marcel Gani (10)
|
36,822
|
*
|
||||||
Doron Inbar (11)
|
126,378
|
*
|
||||||
Avery More (12)
|
186,832
|
*
|
||||||
Tal Payne (13)
|
25,712
|
*
|
||||||
All directors and executive officers as a group (14 individuals)(14)
|
1,431,188
|
2.9
|
%
|
|||||
* |
Represents beneficial ownership of less than 1%.
|
(1) |
Based solely on a Schedule 13G/A filed with the SEC by Blackrock Inc., on February 5, 2020. Schedule 13G/A contains information as of December 31, 2019. Blackrock Inc. reports having power to dispose or to direct the disposition of
over all of the shares reported above. The address of the reporting persons is 55 East 52nd Street New York, NY 10055.
|
(2) |
Based solely on a Schedule 13G/A filed with the SEC by Swedbank Robur Fonder AB., on February 13, 2020. Schedule 13G/A contains information as of December 31, 2019. Swedbank Robur Fonder AB. reports having power to dispose or to
direct the disposition of over all of the shares reported above. The address of the reporting persons is SE-105 34, Stockholm, Sweden.
|
(3) |
Consists of 13,496 shares of common stock owned of record by Mr. Lando, and 23,426 shares of common stock issuable upon exercise of options exercisable within 60 days of March 20, 2020.
|
(4) |
Consists of 48,835 shares of common stock owned of record by Mr. Faier, and 90,581 shares of common stock issuable upon exercise of options exercisable within 60 days of March 20, 2020.
|
(5) |
Consists of 132,857 shares of common stock owned of record by Mr. Galin, and 82,532 shares of common stock issuable upon exercise of options exercisable within 60 days of March 20, 2020.
|
(6) |
Consists of 9,888 shares of common stock owned of record by Ms. Prishkolnik, and 8,918 shares of common stock issuable upon exercise of options exercisable within 60 days of March 20, 2020.
|
(7) |
Consists of 1,359 shares of common stock issuable to Mr. Nadav Zafrir, upon settlement of restricted stock units which will vest and settle within 60 days of March 20, 2020.
|
(8) |
Consists of 22,902 shares of common stock owned of record by Mr. Avida, 2,810 shares of common stock issuable upon settlement of restricted stock units which will vest and settle within 60 days
of March 20, 2020, 50,000 shares of common stock held by Opus Capital Venture Partners L.P.’s investment committee consists of Carl Showalter, Dan Avida, Gill Cogan and Joseph Cutts and 20,630 shares of common stock held by The
Zarbu Revocable Trust, c/o Dan Avida.
|
(9) |
Consists of 44,021 shares of common stock owned of record by Mr. Cheifetz, and 2,810 shares of common stock issuable upon settlement of restricted stock units which will vest and settle within
60 days of March 20, 2020.
|
(10) |
Consists of 22,902 shares of common stock owned of record by Mr. Gani, 2,810 shares of common stock issuable upon settlement of restricted stock units which will vest and settle within 60 days
of March 20, 2020, 5,555 shares of common stock held directly by Marcel Gani 2002 Living Trust and 5,555 shares of common stock held directly by ALGA Partners LLC. Mr. Gani, in his
capacity as trustee, has voting and investment power over the shares owned by the Marcel Gani 2002 Living Trust. Mr. Gani, in his capacity as manager, has voting and investment power over the shares owned by ALGA Partners LLC.
|
(11) |
Consists of 22,902 shares of common stock owned of record by Mr. Inbar, 100,666 shares of common stock issuable upon exercise of options exercisable within 60 days of March 20, 2020, and 2,810
shares of common stock issuable upon settlement of restricted stock units which will vest and settle within 60 days of March 20, 2020.
|
(12) |
Consists of 176,181 shares of common stock owned of record by Mr. More, 2,810 shares of common stock issuable upon settlement of restricted stock units which will vest and settle within 60 days
of March 20, 2020, and 7,841 shares held by Avery More's wife, Jerralyn Smith More, as to which Avery More disclaims any ownership interest.
|
(13) |
Consists of 22,902 shares of common stock owned of record by Ms. Payne, and 2,810 shares of common stock issuable upon settlement of restricted stock units which will vest and settle within 60
days of March 20, 2020.
|
(14) |
Consists of 939,380 shares of common stock, 473,589 shares of common stock issuable upon exercise of options exercisable within 60 days of March 20, 2020, and 18,219 shares of common stock
issuable upon settlement of restricted stock units which will vest and settle within 60 days of March 20, 2020.
|
• |
Our total shareholder return was 171% during 2019, which was higher than all but one of our compensation peer companies, and our market capitalization grew by more than $3 billion during the year to $4.6 billion on December 31, 2019;
|
• |
We reported record revenues of $1.43 billion for the year ending December 31, 2019, representing 52% increase from $937.2 million for the year ending December 31, 2018;
|
• |
GAAP net income for the year ended December 31, 2019 was $146.5 million a 14% increase compared to $128.8 million for the year ended December 31, 2018.
|
• |
Non-GAAP* net income for the year ending December 31, 2019 was $233.2 million a 48% increase compared to $157.3 million for the year ended December 31, 2018;
|
• |
We generated $259.0 million in cash from operating activities for the year ended December 31, 2019, a 37% increase compared to $189.1 for the year ended December 31, 2018.
|
• |
Employee base increased by 40%, to 2,431 full time employees as of December 31, 2019, compared to 1,737 full time employees as of December 31, 2018.
|
• |
We further expanded our global footprint by establishing new subsidiaries in Brazil, Italy and Israel.
|
|
•
|
|
motivate our executives to maximize stockholder value;
|
|
•
|
|
provide compensation that varies based on performance; and
|
|
•
|
|
attract and retain managerial talent, without promoting unreasonable risk-taking.
|
|
•
|
|
ownership guidelines for executive officers which require certain levels of stock ownership;
|
•
|
robust selling restrictions;
|
|
•
|
|
restrictions on hedging and pledging the Company’s common stock;
|
|
•
|
|
use of objective, performance criteria in our incentive plans, including minimum financial parameters in our annual cash incentive compensation plan;
|
|
•
|
|
advice from independent compensation consultants retained by the Compensation Committee; and
|
|
•
|
|
no specific retirement benefit plans designed solely for senior executives or related entitlements such as executive benefits and perquisites, tax gross-ups, etc.
|
•
|
Zivi Lando, our Chief Executive Officer;
|
•
|
Guy Sella, our Former Chief Executive Officer and Chairman of the Board;
|
•
|
Ronen Faier, our Chief Financial Officer;
|
•
|
Uri Bechor, our Chief Operations Officer;
|
•
|
Rachel Prishkolnik, our Vice President, General Counsel and Corporate Secretary; and
|
•
|
Yoav Galin, our Vice President, Research and Development.
|
|
•
|
|
Pay for Financial Performance: Under our annual cash incentive plan, the Compensation Committee determines a set of financial parameters related to revenues, gross margins
and profitability of the Company. If these parameters are not met at a level of at least 70% and profitability is not achieved, the executives are not entitled to compensation under the plan.
|
|
•
|
Pay for Business Performance and Department Goals: Motivate, recognize, and reward business performance based on specific goals in line with the business plan approved by
the Board of Directors.
|
|||
• |
Alignment of Interests: We seek to
align the interests of our senior executives with those of our stockholders.
|
|||
• |
Attraction, Motivation, and Retention of Talent: Our senior executive compensation programs are designed to help us attract,
motivate, and retain key management talent who drive profitability and the creation of stockholder value.
|
Compensation Element
|
Form
|
Objective
|
Rationale / Key Characteristics
|
Base Salary
|
Cash
|
Retention
Attraction
Performance
|
• Fixed compensation
• Intended to be commensurate with each senior executive’s position and level of responsibility
• Evaluated annually or as necessary in response to organizational/business changes, individual performance, market data, etc., but not automatically increased
|
Annual Cash Incentive Compensation
|
Cash
|
Performance
Alignment of Interests
Motivation
|
• Tied to and contingent upon the Company’s financial performance, including revenues, gross margin and profitability.
• Designed to reward achievement of challenging annual performance goals that we consider important contributors to stockholder value
• Performance goals and targets are established by the Compensation Committee at the beginning of each calendar year
• The Compensation Committee approves annual cash incentive award payouts based on the level of achievement of these pre-established goals
|
Long-Term Incentives
|
Stock
Options
|
Performance
Alignment of Interests
Motivation
|
• As options have no value unless the value of our common stock increases, these awards align the interests of senior executives with those of our stockholders
• Options motivate such executives to perform in a manner that drives sustainable increases in the value of our common stock.
|
Restricted Stock Units
|
Performance
Alignment of Interests
Retention
Motivation
|
• Variable compensation designed to reward contributions to our long-term strategic, financial, and operational success, motivate future performance, align the interests of
senior executives with those of stockholders, and retain key senior executives through the term of the awards
• Four year vesting encourages retention as recipients need to remain employed on each vesting date in order for entitlement to occur
|
|
Other Compensation and Benefits
|
N/A
|
Attraction
Retention
|
• NEOs receive benefits that are generally available to all salaried employees in Israel, where the NEOs are located. This includes contributions to an education fund and
to a fund known as Manager’s Insurance, which provides a combination of retirement plan, insurance, and severance pay benefits to Israeli employees.
• NEOs receive benefits that we generally make available to all salaried employees, including participation in the Employee Stock Purchase Plan.
|
Change–in- Control Arrangements
|
Equity
|
Attraction
Retention
|
• Each of our NEOs has a clause in the NEO’s employment agreement that entitles the NEO to immediate vesting of equity in the event of a qualifying termination within one
year following a change in control (“double-trigger” equity vesting)
• Keep management’s highest priority on stockholder interests in the face of events that may result in a change-in-control and not on potential individual implications of
any such events
• Reasonable change-in-control protections for our senior executives are necessary in order for us to attract and retain qualified employees
• We periodically review the necessity and design of our senior executive severance and change-in-control arrangements.
|
Name and Principal Position
|
Annual
base salary in 2018 ($)
|
Annual base salary in 2019 ($)
|
Percentage change
|
Annual base salary effective September 1, 2019*
|
Percentage change
|
Zivi Lando – Chief Executive Officer
|
350,000
|
420,000
|
20.0%
|
625,000
|
48.8%
|
Guy Sella - Former Chief Executive Officer and Chairman of the Board (deceased)
|
611,000
|
750,000
|
22.7%
|
22.7%
|
|
Ronen Faier - Chief Financial Officer
|
350,000
|
420,000
|
20.0%
|
-
|
20.0%
|
Rachel Prishkolnik – Vice President, General Counsel and Corporate Secretary
|
290,000
|
380,000
|
31.0%
|
-
|
31.0%
|
Yoav Galin – Vice President, Research and Development
|
322,000
|
380,000
|
18.0%
|
-
|
18.0%
|
Uri Bechor - Chief Operations Officer
|
-
|
435,000
|
N/A
|
N/A
|
Goal Type
|
Percentage of Total
|
2019 Achievement vs. Goals (Corporate Performance)
|
Revenue
|
30%
|
$1.34 billion in revenue in solar business vs. $1.05 billion Goal (+27%)
|
Net Income
|
10%
|
$146.6 million in net income business vs. $120M Goal (+22%)
|
Gross Margin
|
18%
|
35.8 % in Gross Margin in solar business vs. 33.0% Goal (8%)
|
Non- solar business
|
7%
|
Targets relating to revenues and loss of acquired non-solar businesses (UPS, e-Mobility and storage)
|
Strategy
|
14%
|
Targets which included the integration of research and development and quality assurance teams of the newly acquired businesses.
|
Scalability & Infrastructure
|
10%
|
Targets which focused on building the Company’s manufacturing production capabilities in the north of Israel, building manufacturing capacity in a third global site
|
Operations
|
11%
|
Targets included increasing manufacturing capacity and certain cost reduction initiatives
|
Total
|
100%
|
101.1% of Target Corporate Performance Achieved
|
NEO
|
2019 Bonus Target
|
2019 Actual Bonus
|
2019 Actual Bonus as % of Target*
|
Zivi Lando**
|
395,933
|
397,747
|
100.5%
|
Guy Sella (paid to his estate)
|
750,000
|
758,465
|
101.1%
|
Ronen Faier
|
281,400
|
282,782
|
100.5%
|
Rachel Prishkolnik
|
254,600
|
257,310
|
101.1%
|
Yoav Galin
|
254,600
|
254,600
|
100%
|
Uri Bechor***
|
93,338
|
94,391
|
101.1%
|
|
The Compensation Committee,
Avery More, Chairman
Dan Avida
Doron Inbar
|
•
|
the balance between annual and long-term compensation, including the fact that a significant portion of compensation is delivered in the form of equity incentives that vest over several
years;
|
•
|
the use of multiple financial metrics for performance-based annual cash incentive awards and the use of individual goals under our annual cash incentive program;
|
•
|
the Compensation Committee’s ability to modify annual cash incentives to reflect the quality of earnings, individual performance, and other factors that it believes should influence
compensation; and
|
•
|
our management stock-selling restrictions encourage a longer-term perspective and align the interests of senior executives and the Board, as applicable, with other stockholders.
|
Name and Principal Position
|
Year
|
Salary
($)(1) |
Bonus
($)(1)(2) |
Option Awards ($)(3)
|
Stock Awards ($)(3)
|
Non-Equity Incentive Plan Compensation($)(1)(4)
|
All Other
Compensation ($)(1) |
Total
($) |
Zivi Lando –
Chief Executive Officer
|
2019
|
505,986
|
-
|
548,644
|
549,986
|
397,747
|
79,000 (8)
|
2,081,364
|
2018
|
340,926
|
-
|
410,801
|
436,966
|
235,741
|
56,137(9)
|
1,480,571
|
|
2017
|
343,763
|
-
|
325,242
|
320,010
|
248,474
|
56,302(10)
|
1,293,791
|
|
Guy Sella –
Former Chief Executive Officer and Chairman of the Board
|
2019
|
515,415
|
-
|
1,995,128
|
1,999,999
|
-
|
8,838,469(5)
|
13,349,011
|
2018
|
595,267
|
-
|
1,363,073
|
1,449,971
|
674,897
|
94,973(6)
|
4,178,181
|
|
2017
|
600,221
|
-
|
1,002,437
|
986,343
|
645,219
|
94,261(7)
|
3,328,481
|
|
Ronen Faier –
Chief Financial Officer
|
2019
|
437,246
|
-
|
548,644
|
549,986
|
282,782
|
69,869(11)
|
1,888,527
|
2018
|
340,926
|
-
|
410,801
|
436,966
|
241,714
|
53,689(12)
|
1,484,097
|
|
2017
|
343,763
|
325,242
|
320,010
|
241,153
|
53,725(13)
|
1,283,893
|
||
Rachel Prishkolnik –
VP General Counsel and Corporate Secretary
|
2019
|
395,605
|
-
|
436,436
|
437,487
|
257,310
|
60,808(14)
|
1,587,645
|
2018
|
281,399
|
-
|
248,155
|
527,173
|
198,292
|
46,718(15)
|
1,301,737
|
|
Yoav Galin –
VP Research and Development
|
2019
|
395,605
|
-
|
436,436
|
437,487
|
254,600
|
67,757(16)
|
1,591,885
|
2018
|
313,868
|
-
|
410,801
|
436,966
|
210,688
|
52,303(17)
|
1,424,626
|
|
2017
|
316,480
|
-
|
325,242
|
320,010
|
209,731
|
52,195(18)
|
1,223,658
|
|
Uri Bechor –
Chief Operating Officer
|
2019
|
145,745
|
287,191 |
-
|
850,045
|
94,391
|
23,100(19)
|
1,400,472
|
(1) |
We paid the amounts reported for each NEO in New Israeli Shekels. We have translated amounts paid in New Israeli Shekels into U.S. dollars at the foreign exchange rate published by the Bank
of Israel as of the date of payment.
|
(2) |
Represents the cash payment for sign on bonus earned as part of the employment agreement. For more information, see the discussion in the CD&A
under the caption Annual Cash Incentive.
|
(3) |
The amounts in this column represent the aggregate grant date fair value of the equity-based awards granted to our NEOs,
computed in accordance with FASB ASC Topic 718. We provide information regarding the assumptions used to calculate the value of the equity-based awards in Note 2w to the audited
consolidated financial statements included in our Annual Report on Form 10-K filed on February 27, 2020. There can be no assurance that these awards will vest or will be exercised (in which case no value will be realized by the
individual), or that the value upon exercise will approximate the aggregate grant date fair value.
|
(4) |
Represents the cash bonuses earned pursuant to our annual cash incentive program. For more information, see the discussion in the CD&A under the
caption Annual Cash Incentive.
|
(5) |
Includes: (i) base salary paid to Mr. Sella’s estate for the period September to December 2019 in the amount
of $261,669; (ii) a bonus paid to Mr. Sella’s estate for 2019 in the amount of $758,465; (iii) an accrual of $1,500,000 for base salary and bonus payment to be made to Mr. Sella’s estate in 2020; (iv) 119,298 RSUs and 214,650 options
which vested upon Mr. Sella’s death with a fair value at the grant date of $6,241,979; and (v) a $36,394 contribution by the Company to Mr. Sella’s severance fund and $39,962 in aggregate Company contributions to pension and Israeli
recreational funds and a recuperation allowance.
|
(6) |
Includes a $49,586 contribution by the Company to Mr. Sella’s severance fund and $45,387 in aggregate Company contributions to pension and Israeli
recreational funds and a recuperation allowance.
|
(7) |
Includes a $49,996 contribution by the Company to Mr. Sella’s severance fund and $44,265 in aggregate Company contributions to pension and Israeli
recreational funds and a recuperation allowance.
|
(8) |
Includes a $42,149 contribution by the Company to Mr. Lando’s severance fund and $36,852 in aggregate Company contributions to pension and Israeli
recreational funds and a recuperation allowance.
|
(9) |
Includes a $28,399 contribution by the Company to Mr. Lando’s severance fund and $27,738 in aggregate Company contributions to
pension and Israeli recreational funds and a recuperation allowance.
|
(10) |
Includes a $28,633 contribution by the Company to Mr. Lando’severance fund and $27,669 in aggregate Company contributions to
pension and Israeli recreational funds and a recuperation allowance
|
(11) |
Includes a $35,185 contribution by the Company to Mr. Faier’s severance fund and $34,684 in aggregate Company contributions to pension and Israeli recreational funds and a recuperation
allowance
|
(12) |
Includes a $27,179 contribution by the Company to Mr. Faier’s severance fund and $26,511 in aggregate Company contributions to pension and Israeli recreational funds and a recuperation
allowance.
|
(13) |
Includes a $27,404 contribution by the Company to Mr. Faier’s severance fund and $26,321 in aggregate Company contributions to pension and Israeli recreational funds and a recuperation
allowance.
|
(14) |
Includes a $32,110 contribution by the Company to Ms. Prishkolnik’s severance fund and $28,697 in aggregate Company contributions to pension and Israeli recreational funds and a
recuperation allowance.
|
(15) |
Includes a $22,608 contribution by the Company to Ms. Prishkolnik’s severance fund and $24,110 in aggregate Company contributions to pension and Israeli recreational funds and a
recuperation allowance.
|
(16) |
Includes a $34,409 contribution by the Company to Mr. Galin’s severance fund and $33,348 in aggregate
Company contributions to pension and Israeli recreational funds and a recuperation allowance.
|
(17) |
Includes a $26,145 contribution by the Company to Mr. Galin’s severance fund and $26,158 in aggregate Company contributions to pension and Israeli recreational funds and a recuperation
allowance.
|
(18) |
Includes a $26,363 contribution by the Company to Mr. Galin’s severance fund and $25,832 in aggregate Company contributions to pension and Israeli recreational funds and a recuperation
allowance.
|
(19) |
Includes a $10,959 contribution by the Company to Mr. Bechor’s severance fund and $12,141 in aggregate Company contributions to pension and Israeli recreational funds and a recuperation
allowance.
|
Name
|
Equity Award Grant Date
|
Estimated Future Payouts under Non-Equity Incentive Plan Awards
|
All Other Stock Awards: Number of Shares of Stock or Units
|
All Other Option Awards: Number of Securities Underlying Options
|
Exercise or Base Price of Option Awards ($/Share)
|
Grant Date Fair Value of Stock & Option Awards ($)(1)
|
||
Threshold
($)
|
Target
($)(2)
|
Maximum
($)
|
||||||
Zivi Lando
|
281,400
|
|||||||
01/02/2019
|
27,665
|
36.15
|
548,644
|
|||||
01/02/2019
|
15,214
|
549,986
|
||||||
Guy Sella
|
750,000
|
|||||||
01/02/2019
|
100,603
|
36.15
|
1,995,128
|
|||||
01/02/2019
|
55,325
|
1,999,999
|
||||||
Ronen Faier
|
395,933
|
|||||||
01/02/2019
|
27,665
|
36.15
|
548,644
|
|||||
01/02/2019
|
15,214
|
549,986
|
||||||
Rachel Prishkolnik
|
254,600
|
|||||||
01/02/2019
|
22,007
|
36.15
|
436,436
|
|||||
01/02/2019
|
12,102
|
437,487
|
||||||
Yoav Galin
|
254,600
|
|||||||
01/02/2019
|
22,007
|
36.15
|
436,436
|
|||||
01/02/2019
|
12,102
|
437,487
|
||||||
Uri Bechor
|
93,338
|
|||||||
11/10/2019
|
10,905
|
850,045
|
(1) |
The amounts in this column represent the aggregate grant date fair value of the equity based awards granted to our NEOs, computed in accordance with FASB ASC Topic 718. We provide information regarding the assumptions used to calculate
the value of these equity based awards in Note 2w to the audited consolidated financial statements included in our Annual Report on Form 10-K filed on February 27, 2020. There can be no assurance that these awards will vest or will be
exercised (in which case no value will be realized by the individual), or that the value upon exercise will approximate the aggregate grant date fair value.
|
(2) |
The Non-Equity Incentive Plan does not include any thresholds or a maximum cap for the Non-Equity Incentive Awards; provided, however, that the Named Executive Officers would not be entitled to any payment if the Financial Goals under
the plan were not achieved at 70%.
|
Option Awards
|
Stock Awards
|
||||||
Name
|
Number of
Securities Underlying Unexercised Options Exercisable |
Number of
Securities Underlying Unexercised Options Unexercisable |
Option
Exercise Price ($) |
Option
Expiration Date |
Number of
Shares or Units of Stock that have not Vested |
Market
Value of Shares or Units of Stock that have not Vested ($)* |
|
Zivi Lando
|
3,648
|
$5.01
|
October 29, 2024
|
—
|
—
|
||
7,200
|
—
|
$25.09
|
August 19, 2025
|
—
|
—
|
||
14,449
|
3,335(1)
|
$17.14
|
August 23, 2026
|
—
|
—
|
||
28,151
|
12,797 (2)
|
$14.85
|
February 14, 2027
|
—
|
—
|
||
8,627
|
11,094(3)
|
$38.05
|
January 2, 2028
|
—
|
—
|
||
5,187
|
22,478(4)
|
$36.15
|
January 2, 2029
|
—
|
—
|
||
—
|
—
|
—
|
—
|
1,775(5)
|
$168,785
|
||
—
|
—
|
—
|
—
|
6,921(6)
|
$658,118
|
||
—
|
—
|
—
|
—
|
6,460(7)
|
$614,281
|
||
—
|
—
|
—
|
—
|
12,362(8)
|
$1,175,503
|
||
Guy Sella**
|
577,253
|
—
|
$5.01
|
September 1, 2020
|
—
|
—
|
|
48,000
|
—
|
$25.09
|
February 25, 2021
|
—
|
—
|
||
54,813
|
—
|
$17.14
|
February 25, 2021
|
—
|
—
|
||
126,207
|
—
|
$14.85
|
February 25, 2021
|
—
|
—
|
||
65,436
|
—
|
$38.05
|
February 25, 2021
|
—
|
—
|
||
100,603
|
—
|
$36.15
|
February 25, 2021
|
||||
Ronen Faier
|
8,333
|
—
|
$5.01
|
October 29, 2024
|
—
|
—
|
|
19,200
|
—
|
$25.09
|
August 19, 2025
|
—
|
—
|
||
14,449
|
3,335 (1)
|
$17.14
|
August 23, 2026
|
—
|
—
|
||
28,151
|
12,797 (2)
|
$14.85
|
February 14, 2027
|
—
|
—
|
||
8,627
|
11,094 (3)
|
$38.05
|
January 2, 2028
|
—
|
—
|
||
5,187
|
22,478 (4)
|
$36.15
|
January 2, 2029
|
—
|
—
|
||
—
|
—
|
—
|
—
|
1,775 (5)
|
$168,785
|
||
—
|
—
|
—
|
—
|
6,921 (6)
|
$658,118
|
||
—
|
—
|
—
|
—
|
6,460 (7)
|
$614,281
|
||
—
|
—
|
—
|
—
|
12,362 (8)
|
$1,175,503
|
||
Rachel Prishkolnik
|
700
|
—
|
$25.09
|
August 19, 2025
|
—
|
—
|
|
1,295
|
1,943 (1)
|
$17.14
|
August 23, 2026
|
—
|
—
|
||
6,030
|
7,455 (2)
|
$14.85
|
February 14, 2027
|
—
|
—
|
||
5,211
|
6,702 (3)
|
$38.05
|
January 2, 2028
|
—
|
—
|
||
4,126
|
17,881(4)
|
$36.15
|
January 2, 2029
|
—
|
—
|
||
—
|
—
|
—
|
—
|
1,034 (5)
|
$98,323
|
||
—
|
—
|
—
|
—
|
4,032 (6)
|
$383,403
|
||
—
|
—
|
—
|
—
|
4,967 (7)
|
$472,312
|
||
—
|
—
|
—
|
—
|
3,776 (8)
|
$359,060
|
||
—
|
—
|
—
|
—
|
9,833 (9)
|
$935,020
|
||
Yoav Galin
|
12,499
|
—
|
$5.01
|
October 29, 2024
|
—
|
—
|
|
8,400
|
—
|
$25.09
|
August 19, 2025
|
—
|
—
|
||
14,449
|
3,335 (1)
|
$17.14
|
August 23, 2026
|
—
|
—
|
||
28,151
|
12,797 (2)
|
$14.85
|
February 14, 2027
|
—
|
—
|
||
8,627
|
11,094 (3)
|
$38.05
|
January 2, 2028
|
—
|
—
|
||
4,126
|
17,881(4)
|
$36.15
|
January 2, 2029
|
—
|
—
|
||
—
|
—
|
—
|
—
|
1,775 (5)
|
$168,785
|
||
—
|
—
|
—
|
—
|
6,921 (6)
|
$658,118
|
||
—
|
—
|
—
|
—
|
6,460 (7)
|
$614,281
|
||
—
|
—
|
—
|
—
|
9,833 (8)
|
$935,020
|
||
Uri Bechor
|
—
|
—
|
—
|
—
|
10,905 (10)
|
$1,036,956
|
* |
The market value of shares or units of stock that have not vested is based on the number of shares or units of stock that have not vested multiplied by the closing price of our common stock on the last trading day of the year ended
December 31, 2019 ($95.09).
|
** |
Upon the untimely passing of Mr. Sella on August 25, 2019, all unvested shares and options held by him vested.
|
(1) |
The shares subject to the stock option vest over a four‑year period commencing August 31, 2016, with 1/16 of the shares vesting quarterly thereafter.
|
(2) |
The shares subject to the stock option vest over a four‑year period commencing February 28, 2017, with 1/16 of the shares vesting quarterly thereafter.
|
(3) |
The shares subject to the stock option vest over a four‑year period commencing February 28, 2018 with 1/16 of the shares vesting quarterly thereafter.
|
(4) |
The shares subject to the stock option vest over a four‑year period commencing February 28, 2019 with 1/16 of the shares vesting quarterly thereafter.
|
(5) |
The shares subject to the RSU vest over a four-year period commencing on August 31, 2016, with 1/16 of the shares vesting quarterly thereafter.
|
(6) |
The shares subject to the RSU vest over a four-year period commencing on February 28, 2017, with 1/16 of the shares vesting quarterly thereafter.
|
(7) |
The shares subject to the RSU vest over a four-year period commencing on February 28, 2018, with 1/16 of the shares vesting quarterly thereafter.
|
(8) |
The shares subject to the RSU vest over a four-year period commencing on February 28, 2019, with 1/16 of the shares vesting quarterly thereafter.
|
(9) |
The shares subject to the RSU vest over a four-year period commencing on November 30, 2018, with 1/16 of the shares vesting quarterly thereafter.
|
(10) |
The shares subject to the RSU vest over a four-year period commencing on November 30, 2019, with 1/16 of the shares vesting quarterly thereafter.
|
Option Awards
|
Stock Awards
|
|||||||||||||||
Name
|
Number of Shares Acquired on Exercise
|
Value Realized upon Exercise ($)(2)
|
Number of Shares
Acquired on Vesting |
Value Realized on
Vesting ($)(3) |
||||||||||||
Zivi Lando
|
143,018
|
$
|
11,317,268
|
16,326
|
$
|
1,070,067
|
||||||||||
Guy Sella(1)
|
-
|
-
|
144,196
|
$
|
10,917,227
|
|||||||||||
Ronen Faier
|
50,000
|
$
|
3,981,198
|
16,326
|
$
|
1,070,067
|
||||||||||
Rachel Prishkolnik
|
27,940
|
$
|
1,955,549
|
11,914
|
$
|
784,520
|
||||||||||
Yoav Galin
|
-
|
-
|
15,743
|
$
|
1,027,662
|
|||||||||||
Uri Bechor
|
-
|
-
|
-
|
-
|
Name: Zivi Lando
|
Termination
upon Death
of Employee
|
Termination
for Cause
|
Voluntary
Termination
by Employee
After
Provision of
Requisite
Notice
|
Termination
by Company
After
Provision of
Requisite
Notice
|
Termination
w/o Cause within
12 months of
Change in
Control(2)
|
|||||||||||||||
Base Salary
|
-
|
-
|
158,121
|
158,121
|
158,121
|
|||||||||||||||
Israeli Social Benefits
|
-
|
-
|
28,258
|
28,258
|
28,258
|
|||||||||||||||
Unvested Options/RSUs (1)
|
-
|
-
|
810,840
|
810,840
|
5,861,136
|
|||||||||||||||
Accrued Vacation Pay
|
328,986
|
328,986
|
328,986
|
328,986
|
328,986
|
|||||||||||||||
TOTAL
|
328,986
|
328,986
|
1,326,205
|
1,326,205
|
6,376,501
|
(1) |
The value realized is based on the difference between the exercise price of the stock options and the closing price of our common stock on the last trading day of the year ended December 31, 2019, and, in the case of RSUs, the number
of RSUs that would have vested multiplied by the closing price of our common stock on the last trading day of the year ended December 31, 2019.
|
Name: Ronen Faier
|
Termination
upon Death
of Employee
|
Termination
for Cause
|
Voluntary
Termination
by Employee
After
Provision of
Requisite
Notice
|
Termination
by Company
After
Provision of
Requisite
Notice
|
Termination
w/o Cause or
for Good
Reason within
12 months of
Change in
Control
|
|||||||||||||||
Base Salary
|
-
|
-
|
112,329
|
112,329
|
112,329
|
|||||||||||||||
Israeli Social Benefits
|
-
|
-
|
20,625
|
20,625
|
20,625
|
|||||||||||||||
Unvested Options/RSUs (1)
|
-
|
-
|
810,840
|
810,840
|
5,861,136
|
|||||||||||||||
Accrued Vacation Pay
|
166,883
|
166,883
|
166,883
|
166,883
|
166,883
|
|||||||||||||||
TOTAL
|
166,883
|
166,883
|
1,110,677
|
1,110,677
|
6,160,973
|
(1) |
The value realized is based on the difference between the exercise price of the stock options and the closing price of our common stock on the last trading day of the year ended December 31, 2019, and, in the case of RSUs, the number
of RSUs that would have vested multiplied by the closing price of our common stock on the last trading day of the year ended December 31, 2019.
|
Name: Rachel Prishkolnik
|
Termination
upon Death
of Employee
|
Termination
for Cause
|
Voluntary
Termination
by Employee
After
Provision of
Requisite
Notice
|
Termination
by Company
After
Provision of
Requisite
Notice
|
Termination
w/o Cause or
for Good
Reason within
12 months of
Change in
Control
|
|||||||||||||||
Base Salary
|
-
|
-
|
101,631
|
101,631
|
101,631
|
|||||||||||||||
Israeli Social Benefits
|
-
|
-
|
18,168
|
18,168
|
18,168
|
|||||||||||||||
Unvested Options/RSUs (1)
|
-
|
-
|
557,371
|
557,371
|
4,433,952
|
|||||||||||||||
Accrued Vacation Pay
|
120,403
|
120,403
|
120,403
|
120,403
|
120,403
|
|||||||||||||||
TOTAL
|
120,403
|
120,403
|
797,573
|
797,573
|
4,674,154
|
(1) |
The value realized is based on the difference between the exercise price of the stock options and the closing price of our common stock on the last trading day of the year ended December 31, 2019, and, in the case of RSUs, the number
of RSUs that would have vested multiplied by the closing price of our common stock on the last trading day of the year ended December 31, 2019.
|
Name: Yoav Galin
|
Termination
upon Death
of Employee
|
Termination
for Cause
|
Voluntary
Termination
by Employee
After
Provision of
Requisite
Notice
|
Termination
by Company
After
Provision of
Requisite
Notice
|
Termination
w/o Cause or
for Good
Reason within
12 months of
Change in
Control
|
|||||||||||||||
Base Salary
|
-
|
-
|
101,631
|
101,631
|
101,631
|
|||||||||||||||
Israeli Social Benefits
|
-
|
-
|
19,410
|
19,410
|
19,410
|
|||||||||||||||
Unvested Options/RSUs (1)
|
-
|
-
|
771,433
|
771,433
|
4,295,800
|
|||||||||||||||
Accrued Vacation Pay
|
468,135
|
468,135
|
468,135
|
468,135
|
468,135
|
|||||||||||||||
TOTAL
|
468,135
|
468,135
|
1,360,609
|
1,360,609
|
4,884,976
|
(1) |
The value realized is based on the difference between the exercise price of the stock options and the closing price of our common stock on the last trading day of the year ended December 31, 2019, and, in the case of RSUs, the number
of RSUs that would have vested multiplied by the closing price of our common stock on the last trading day of the year ended December 31, 2019.
|
Name: Uri Bechor
|
Termination
upon Death
of Employee
|
Termination
for Cause
|
Voluntary
Termination
by Employee
After
Provision of
Requisite
Notice
|
Termination
by Company
After
Provision of
Requisite
Notice
|
Termination
w/o Cause within
12 months of
Change in
Control(2)
|
|||||||||||||||
Base Salary
|
-
|
-
|
220,320
|
220,320
|
220,320
|
|||||||||||||||
Israeli Social Benefits
|
-
|
-
|
40,071
|
40,071
|
40,071
|
|||||||||||||||
Unvested Options/RSUs (1)
|
-
|
-
|
-
|
-
|
6,665,429
|
|||||||||||||||
Accrued Vacation Pay
|
10,726
|
10,726
|
10,726
|
10,726
|
10,726
|
|||||||||||||||
TOTAL
|
10,726
|
10,726
|
271,117
|
271,117
|
6,936,546
|
(1) |
The value realized is based on the difference between the exercise price of the stock options and the closing price of our common stock on the last trading day of the year ended December 31, 2019, and, in the case of RSUs, the number
of RSUs that would have vested multiplied by the closing price of our common stock on the last trading day of the year ended December 31, 2019.
|
Position
|
2019
Retainer ($)
|
|||
Board Member
|
55,000
|
|||
Audit Committee Chair
|
25,000
|
|||
Compensation Committee Chair
|
17,500
|
|||
Nominating and Corporate Governance Committee Chair
|
10,000
|
|||
Audit Committee Non-Chair Member
|
12,500
|
|||
Compensation Committee Non-Chair Member
|
7,500
|
|||
Nominating and Corporate Governance Committee Non-Chair Member
|
5,000
|
Name
|
Fees Earned or Paid in Cash ($)
|
Stock Awards ($)
|
Total ($)
|
|||||||||
Nadav Zafrir
|
22,775
|
265,080
|
287,855
|
(1)
|
||||||||
Dan Avida
|
67,500
|
155,000
|
(2)
|
222,500
|
||||||||
Yoni Cheifetz
|
-
|
155,000
|
(2)
|
155,000
|
||||||||
Marcel Gani
|
80,000
|
155,000
|
(2)
|
235,000
|
||||||||
Doron Inbar
|
75,000
|
155,000
|
(2)
|
230,000
|
||||||||
Avery More
|
82,500
|
155,000
|
(2)
|
237,500
|
||||||||
Tal Payne
|
67,500
|
155,000
|
(2)
|
222,500
|
(1) |
Represents a prorated cash retainer for the appointment as chairman of the board, an initial equity award in the form of restricted stock units, granted upon the initial appointment to our Board of Directors, with a grant date value of
$150,000, and a pro-rated annual equity award in the form of restricted stock units with a grant date value of $115,080 for 2019. The grant date fair value is based on $84.69 per share, the closing price of our share on the grant date. As
of December 31, 2019, the chairman of the board held 3,130 unvested restricted stock units.
|
(2) |
Represents the grant date fair value of 2,810 restricted stock units granted to each director on June 5, 2019, calculated in accordance with U.S. GAAP. All units will become fully vested on May 20, 2020. The grant date fair value is
based on $55.16 per share, the closing price of our share on the grant date. As of December 31, 2019, each director held 2,810 unvested restricted stock units.
|
Reconciliation of GAAP to Non-GAAP Net income attributable to Solaredge Technologies Inc.
|
||||||||||||||||||||
Three months ended
|
Year ended
|
|||||||||||||||||||
December 31, 2019
|
September 30, 2019
|
December 31, 2018
|
December 31, 2019
|
December 31, 2018
|
||||||||||||||||
Net income attributable to Solaredge Technologies Inc. (GAAP)
|
52,778
|
41,627
|
12,936
|
146,549
|
128,833
|
|||||||||||||||
Cost of product adjustment
|
448
|
107
|
398
|
1,556
|
606
|
|||||||||||||||
Stock-based compensation
|
9,446
|
11,367
|
8,691
|
41,889
|
30,618
|
|||||||||||||||
Amortization and depreciation of acquired assets
|
2,093
|
3,409
|
225
|
10,764
|
557
|
|||||||||||||||
Acquisition related expenses
|
-
|
----
|
2,140
|
949
|
2,140
|
|||||||||||||||
Assets disposal
|
56
|
14
|
435
|
622
|
435
|
|||||||||||||||
Non recurring opearting expenses
|
22,391
|
8,305
|
----
|
30,696
|
----
|
|||||||||||||||
Non cash interest
|
1,055
|
955
|
769
|
3,645
|
2,489
|
|||||||||||||||
Currency fluctuation due to new lease standard adoption
|
266
|
800
|
----
|
2,591
|
----
|
|||||||||||||||
Deferred tax realized (asset)
|
(1,114
|
)
|
(2,963
|
)
|
(2,304
|
)
|
(6,037
|
)
|
(7,093
|
)
|
||||||||||
Transition tax of foreign earnings
|
-
|
----
|
8,189
|
----
|
(1,296
|
)
|
||||||||||||||
Net income attributable to Solaredge Technologies Inc. (Non-GAAP)
|
87,419
|
63,621
|
31,479
|
233,224
|
157,289
|